Search Results - "Spalinger, M"

Refine Results
  1. 1

    PTPN2 controls differentiation of CD4+ T cells and limits intestinal inflammation and intestinal dysbiosis by Spalinger, M R, Kasper, S, Chassard, C, Raselli, T, Frey-Wagner, I, Gottier, C, Lang, S, Atrott, K, Vavricka, S R, Mair, F, Becher, B, Lacroix, C, Fried, M, Rogler, G, Scharl, M

    Published in Mucosal immunology (01-07-2015)
    “…Loss-of-function variants within the gene locus encoding protein tyrosine phosphatase non-receptor type 2 (PTPN2) are associated with increased risk for…”
    Get full text
    Journal Article
  2. 2

    The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis by Raselli, T, Wyss, A, Gonzalez Alvarado, M N, Weder, B, Mamie, C, Spalinger, M R, Van Haaften, W T, Dijkstra, G, Sailer, A W, Imenez Silva, P H, Wagner, C A, Tosevski, V, Leibl, Sebastian, Scharl, M, Rogler, G, Hausmann, M, Misselwitz, B

    Published in Journal of Crohn's and colitis (19-09-2019)
    “…Intestinal fibrosis and stenosis are common complications of Crohn's disease [CD], frequently requiring surgery. Anti-inflammatory strategies can only…”
    Get full text
    Journal Article
  3. 3

    The influence of soil remediation on lead in house dust by von Lindern, Ian H., Spalinger, Susan M., Bero, Bridget N., Petrosyan, Varduhi, von Braun, Margrit C.

    Published in Science of the total environment (15-02-2003)
    “…Lead in house dust has long been recognized as a principal source of excess lead absorption among children at the Bunker Hill Superfund Site (BHSS) in northern…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Evaluation of the integrated exposure uptake biokinetic (IEUBK) model for lead in children by Brown, James S., Spalinger, Susan M., Weppner, Sarah G., Hicks, Kynan J. Witters, Thorhaug, Mara, Thayer, William C., Follansbee, Mark H., Diamond, Gary L.

    “…Background The Integrated Exposure Uptake Biokinetic Model for Lead in Children (IEUBK model) was developed by the U.S. Environmental Protection Agency to…”
    Get full text
    Journal Article
  5. 5

    Admixture of a Multivitamin Preparation to Parenteral Nutrition: The Major Contributor to In Vitro Generation of Peroxides by Lavoie, Jean-Claude, Belanger, Sylvie, Spalinger, Monica, Chessex, Philippe

    Published in Pediatrics (Evanston) (01-03-1997)
    “…Peroxides have been reported to contaminate lipid emulsions and amino acid solutions used in total parenteral nutrition (TPN). This is particularly disturbing…”
    Get full text
    Journal Article
  6. 6

    Seasonal variations of lead concentration and loading rates in residential house dust in northern Idaho by Petrosyan, Varduhi, von Braun, Margrit C., Spalinger, Susan M., von Lindern, Ian H.

    Published in Journal of hazardous materials (30-04-2006)
    “…Although lead hazards to humans have been known since ancient times and many regulatory actions and lead risk reductions have been achieved over the past…”
    Get full text
    Journal Article
  7. 7

    Environmental Lead Contamination in the Rudnaya Pristan – Dalnegorsk Mining and Smelter District, Russian Far East by von Braun, Margrit C., von Lindern, Ian H., Khristoforova, Nadezhda K., Kachur, Anatoli H., Yelpatyevsky, Pavel V., Elpatyevskaya, Vera P., Spalinger, Susan M.

    Published in Environmental research (01-03-2002)
    “…A preliminary survey of a remote mining and smelting region of the Russian Far East (RFE) indicates significant soil lead contamination and a high probability…”
    Get full text
    Journal Article
  8. 8

    P061 The macrophage-specific role of PTPN23 in Acute and Chronic Colitis by Linzmeier, L, Matus, V, Determann, M, Wilmink, M, Schwarzfischer, M, Sanchez Alvarez, R, Pöhlmann, D, Scharl, M, Spalinger, M

    Published in Journal of Crohn's and colitis (24-01-2024)
    “…Abstract Background Single nucleotide polymorphisms within the gene locus encoding PTPN2, are associated with Crohn’s disease and ulcerative colitis. We have…”
    Get full text
    Journal Article
  9. 9

    DOP51 Loss of PTPN23 in the intestinal epithelium results in epithelial hyperproliferation and lethal diarrhea in a microbiota dependent manner by Spalinger, M, Sanchez Alvarez, R, Gottier, C, Montalban-Arques, A, Schwarzfischer, M, Niechcial, A, Scharl, M

    Published in Journal of Crohn's and colitis (21-01-2022)
    “…Abstract Background Protein tyrosine phosphtase non-receptor type 23 (PTPN23) plays a critical role in regulating epidermal growth factor (EGF) receptor…”
    Get full text
    Journal Article
  10. 10

    P025 Identification and validation of predictors for tofacitinib through supervised and unbiased approaches in Inflammatory Bowel Disease by Liu, B, Spalinger, M, Perez, L G, Machicote, A, Gagliani, N, Scharl, M, Huber, S

    Published in Journal of Crohn's and colitis (27-05-2021)
    “…Abstract Background Inflammatory Bowel Disease (IBD) is characterized by an overwhelming gut inflammation, where CD4+ effector T cells are main mediators of…”
    Get full text
    Journal Article
  11. 11

    P006 Loss of protein tyrosine phosphatase non-receptor type 23 (PTPN23) in intestinal epithelial cells induces inflammation and epithelial hyperproliferation by Montalban-Arques, A, Gottier, C, Olivares-Rivas, I, Scharl, M, Spalinger, M

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background Colorectal carcinoma (CRC) is still a mayor complication in patients with inflammatory bowel disease (IBD) with colonic involvement…”
    Get full text
    Journal Article
  12. 12

    P033 Combination of vedolizumab with tacrolimus is more efficient in reducing intestinal inflammation than vedolizumab alone in the DSS-induced acute colitis mouse model by Manzini, R, Atrott, K, Schwarzfischer, M, Laimbacher, A, Lang, S, Rogler, G, Scharl, M, Spalinger, M R

    Published in Journal of Crohn's and colitis (15-01-2020)
    “…Abstract Background The humanised monoclonal antibody vedolizumab is used in the treatment of ulcerative colitis (UC) and Crohn’s disease (CD). Vedolizumab…”
    Get full text
    Journal Article
  13. 13

    P068 Loss of PTPN22 abrogates the beneficial effect of faecal microbiota transfer by Spalinger, M, Schwarzfischer, M, Gottier, C, Hering, L, Lang, S, Rogler, G, Scharl, M

    Published in Journal of Crohn's and colitis (16-01-2018)
    “…Abstract Background In inflammatory bowel disease (IBD), shifts in microbiota composition and reduced microbial diversity have been described. There are…”
    Get full text
    Journal Article
  14. 14

    OP030 Loss of PTPN2 in dendritic cells promotes T-cell activation and expression of co-stimulatory molecules by Hering, L, Gottier, C, Lang, S, Becher, B, Rogler, G, Scharl, M, Spalinger, M

    Published in Journal of Crohn's and colitis (16-01-2018)
    “…Abstract Background Variants within the gene locus encoding protein tyrosine phosphatase non-receptor type 2 (PTPN2) are associated with the development of…”
    Get full text
    Journal Article
  15. 15

    DOP079 Heat-shock protein GP96 is essential for self-renewal of the intestinal epithelial barrier by Schwarzfischer, M, Morsy, Y, Atrott, K, Stanzel, C, Lang, S, Rogler, G, Scharl, M, Spalinger, M

    Published in Journal of Crohn's and colitis (16-01-2018)
    “…Abstract Background The intestinal epithelium constitutes an important barrier that separates the body from the external environment to prevent access of…”
    Get full text
    Journal Article
  16. 16

    DOP02 Supplementation with butyrate producing bacteria reduces tumour load in a mouse model of colitis-associated cancer by Montalban Arques, A, Olivares Rivas, I, Atrott, K, Gottier, C, Lang, S, Leventhal, G, DeWouters, T, Scharl, M, Spalinger, M

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background Colorectal carcinoma is still a severe complication in patients with long-standing and severe ulcerative colitis. Current guidelines…”
    Get full text
    Journal Article
  17. 17

    P052 Heat shock protein GP96 is essential for maintaining intestinal epithelial architecture by supporting its self-renewal capacity by Häfliger, J, Schwarzfischer, M, Van de Sande, M, Manzini, R, Stanzel, C, Atrott, K, Lang, S, Scharl, M, Spalinger, M

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background The intestinal epithelium is characterised by a remarkable self-renewal capacity and a high turnover of intestinal epithelial cells (IEC),…”
    Get full text
    Journal Article
  18. 18

    DOP14 TiO2 nanoparticles abrogate the protective effect of the autoimmunity-associated PTPN22R619W variant during acute DSS colitis by Schwarzfischer, M, Hering, L, Katkeviciute, E, Niechcial, A, Atrott, K, Bäbler, K, Busenhart, P, Rogler, G, Scharl, M, Spalinger, M

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background Titanium dioxide (TiO2), commonly used in comestible goods and personal care products, is omnipresent in everyone’s daily life. TiO2…”
    Get full text
    Journal Article
  19. 19

    DOP19 Spermidine treatment ameliorates experimental colitis in vivo by Niechcial, A, Katkeviciute, E, Hering, L, Wawrzyniak, M, Schwarzfischer, M, Bäbler, K, Attrot, K, Scharl, M, Spalinger, M R

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background Genetic variations within the gene encoding protein tyrosine phosphatase non-receptor type 2 (PTPN2) are associated with an increased risk…”
    Get full text
    Journal Article
  20. 20

    Glutathione synthetic activity in the lungs in newborn guinea pigs by Lavoie, J C, Spalinger, M, Chessex, P

    Published in Lung (1999)
    “…Depletion of glutathione, a key antioxidant, accelerates lung injury. Glutathione concentrations are reduced significantly in premature infants with…”
    Get full text
    Journal Article